Moderna, Inc. logo

Moderna, Inc. (MRNA)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
154. 27
+13.93
+9.9259%
$
55.68B Market Cap
- P/E Ratio
- Div Yield
25.69M Volume
-13.23 Eps
$ 140.34
Previous Close
Add Transaction
Day Range
138.09 154.7
Year Range
22.28 176.66
Want to track MRNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Moderna, Inc. (MRNA) Statistics

Valuation metrics

Market Cap 55.68B
Enterprise value 54.32B
Trailing P/E (ttm) -17.29
Forward P/E -11.15
PEG ratio 2.05
Price/Sales (ttm) 24.57
Price/Book (mrq) 8.08
Enterprise Value/Revenue 24.38
Enterprise Value/EBITDA -19.2

Overview

Shares outstanding 396.59M
Float 370.1M
Shares short 58.31M
% Held by insiders 0.07%
% Held by institutions 0.79%
Average volume (10 days) 62.87M
Average volume (90 days) 18.85M

Price summary

52-Week low 22.28
52-Week high 176.66
Beta 1.06
50-Day moving average 91.14
200-Day moving average 59.2

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 3 Aug 2017

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -1.41%
Operating margin -1.49%

Operational effectiveness

Return on assets -0.29%
Return on equity -0.39%

Income Statement

Revenue (ttm) 2.22B
Revenue per share (ttm) 5.63
Quarterly revenue growth (yoy) 2.6%
Gross profit (ttm) -1.56B
EBITDA -2.3B
Net income to common (ttm) -3.19B
Diluted EPS (ttm) -7.96
Quarterly earnings growth (yoy) 2.64%

Balance Sheet

Total cash (mrq) 5.21B
Total cash per share (mrq) 12.97
Total debt (mrq) 1.3B
Total Debt/Equity (mrq) 0.19
Current ratio (mrq) 2.29%
Book value per share (mrq) 17.07

Cash Flow

Cash flow statement -1.47B
Levered free cash flow (LFCF) -20M